This study will evaluate the intraocular pressure-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty in patients with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication.
| Condition | Glaucoma, Open-Angle Ocular Hypertension, Open-Angle Ocular Hypertension, Open-Angle Ocular Hypertension, Open-Angle Ocular Hypertension, Open-Angle Ocular Hypertension, Open-Angle Ocular Hypertension, Open-Angle Ocular Hypertension, Open-Angle Ocular Hypertension, Open-Angle Ocular Hypertension, Open-Angle Ocular Hypertension, Open-Angle Ocular Hypertension |
|---|---|
| Treatment | Selective laser trabeculoplasty, Bimatoprost SR, Sham Bimatoprost SR, Sham Selective Laser Trabeculoplasty |
| Clinical Study Identifier | NCT02636946 |
| Sponsor | Allergan |
| Last Modified on | 21 May 2022 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.